tiprankstipranks
Nippon Sanso Holdings Corporation (JP:4091)
:4091
Japanese Market
Want to see JP:4091 full AI Analyst Report?

Nippon Sanso Holdings Corporation (4091) Earnings Dates, Call Summary & Reports

6 Followers

Earnings Data

Report Date
Jul 29, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
82.01
Last Year’s EPS
65.6
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Feb 04, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented solid operational and financial progress: mid-single digit revenue growth, stronger core operating income and margin expansion, significant operating cash flow improvement, strategic M&A to expand regional footprints, and successful refinancing that reduces interest costs. Offsets include volume softness in parts of the business, regionally mixed profitability (Asia & Oceania pressures), a substantial increase in investing outflows and a meaningful free cash flow decline, plus project execution and leverage implications from acquisitions and suspended projects. On balance the positive execution on pricing, productivity, margin expansion, backlog size, and strategic deals outweigh the near-term cash/volume challenges.
Company Guidance
The company kept full-year sales guidance unchanged at ¥1.3 trillion while raising core operating income (COI) by ¥8.0 billion (up 4.5%) to ¥185.0 billion and nudging operating income up ¥1.0 billion to ¥178.0 billion; pre-tax income is projected at ¥156.5 billion and net income at ¥110.0 billion (¥107.0 billion attributable to the parent). Q3 trends that underpin the guidance included revenue +3.8% (ex-currency ~+1.2%), COI +7.5% (ex-currency +4.5%), COI margin +50 bps to 14.1% and EBITDA margin +50 bps to 23%; the Q3 consolidated variance breakdown was currency +2.6%, price +2.0%, volume -1.4%, pass-through +0.4% and other +0.2%. Management assumes USD/JPY ¥152.45 and EUR/JPY ¥165.83 for Q4, and notes currency sensitivity of ~¥2.4 billion revenue / ¥350 million COI per ¥1 vs USD and ~¥1.9 billion revenue / ¥350 million COI per ¥1 vs EUR. Key cash and investment metrics cited were backlog ≈¥170 billion (projects ≥¥500 million), operating cash flow up ~19% year-to-date (~¥24 billion), free cash flow down ~31% YTD due to higher CapEx and M&A, and refinancing of ¥75 billion hybrid debt in Q3 (¥175 billion refinanced in ~1 year) saving roughly 90 basis points in annual effective interest expense.
Consolidated Revenue Growth
Q3 revenue increased 3.8% year-over-year (Oct–Dec 2024). Excluding favorable currency, revenue rose ~1.2%. Management maintained full-year sales guidance at ¥1.3 trillion.
Core Operating Income and Margin Improvement
Core operating income (COI) increased 7.5% year-over-year (ex-currency +4.5%). COI margin expanded by 50 basis points to 14.1%. EBITDA margin also improved by 50 basis points to 23%.
Strong Operating Cash Flow and Financial Actions
Operating cash flow improved ~19% year-to-date (about ¥24 billion). The company refinanced ¥75 billion of hybrid debt in Q3 (¥175 billion refinanced in just over one year), saving nearly 90 basis points in effective interest expense per annum.
Upward Revision to COI Guidance
Core operating income guidance was revised up by ¥8 billion (4.5%) to ¥185 billion; operating income guidance increased by ¥1 billion to ¥178 billion. Net income forecast for the year is ¥110 billion (¥107 billion attributable to parent).
Backlog and Growth-related Projects
Backlog of projects (≥¥500 million) as of Dec 31, 2024 is approximately ¥170 billion, with environment/hydrogen‑related projects accounting for roughly 45% of the backlog, indicating sizable future CapEx-driven growth opportunities.
Strategic Acquisitions to Expand Geographic and Service Footprint
Announced acquisitions: Coregas Group (Australia/New Zealand) and Esteve Teijin Healthcare (Spain). Coregas expected to increase the company’s presence in Australia by ~50% (raising Australia’s share of Asia & Oceania sales from ~30% to ~40%). The Spain homecare acquisition expands European medical/homecare footprint (asset <3% of group revenue). Both deals targeted to close mid‑2025 pending approvals.
Segment Standouts — Europe and U.S.
Europe: revenue ¥83.3 billion, +10.0% YoY (ex-FX +6.9%); segment income ¥15.4 billion, +16.4% YoY (ex-FX +13.2%). U.S.: revenue ¥90.5 billion, +3.3% YoY (but ex-FX -2.1%); segment income ¥13.5 billion, +9.3% YoY (ex-FX +3.4%).
Thermos Business Resilience
Thermos revenue ¥8.0 billion, +3.3% YoY; segment profit ¥1.6 billion, +11.8% YoY (design/product updates helped offset yen-driven cost increases).

Nippon Sanso Holdings Corporation (JP:4091) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

JP:4091 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 2026
2026 (Q1)
82.01 / -
65.6
May 11, 2026
2025 (Q4)
76.55 / 71.04
49.2144.36% (+21.83)
Feb 04, 2026
2025 (Q3)
78.71 / 82.51
65.3426.28% (+17.17)
Oct 30, 2025
2025 (Q2)
70.24 / 67.07
46.4644.36% (+20.61)
Jul 31, 2025
2025 (Q1)
70.23 / 65.60
67.19-2.37% (-1.59)
May 12, 2025
2024 (Q4)
61.22 / 49.21
75.096-34.47% (-25.89)
Feb 05, 2025
2024 (Q3)
68.16 / 65.34
57.413.83% (+7.94)
Oct 31, 2024
2024 (Q2)
69.11 / 46.46
55.42-16.17% (-8.96)
Jul 30, 2024
2024 (Q1)
63.07 / 67.19
56.7418.42% (+10.45)
May 13, 2024
2023 (Q4)
71.86 / 75.10
47.77857.18% (+27.32)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

JP:4091 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 11, 2026
¥5636.00¥6199.00+9.99%
Feb 04, 2026
¥4863.87¥5249.96+7.94%
Oct 30, 2025
¥5066.86¥5063.88-0.06%
Jul 31, 2025
¥5670.41¥5319.05-6.20%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nippon Sanso Holdings Corporation (JP:4091) report earnings?
Nippon Sanso Holdings Corporation (JP:4091) is schdueled to report earning on Jul 29, 2026, TBA (Confirmed).
    What is Nippon Sanso Holdings Corporation (JP:4091) earnings time?
    Nippon Sanso Holdings Corporation (JP:4091) earnings time is at Jul 29, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Nippon Sanso Holdings Corporation stock?
          The P/E ratio of Nippon Sanso Holdings Corporation is N/A.
            What is JP:4091 EPS forecast?
            JP:4091 EPS forecast for the fiscal quarter 2026 (Q1) is 82.01.